Oxford BioMedica (LSE:OXB) FCF Yield %: -0.56 (As of Jun. 29, 2026)


LSE:OXB Oxford BioMedica PLC LSE:OXB
68 GF Score
Price £6.33
GF Value £5.36
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Oxford BioMedica FCF Yield %?

Oxford BioMedica LSE:OXB -0.16% 68 FCF Yield % is -0.56 as of Jun. 29, 2026. GuruFocus rates LSE:OXB with a GF Score™ of 68/100 and a GF Value™ of £5.36 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,415 Biotechnology companies, Oxford BioMedica ranks better than 81.13% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Oxford BioMedica's Trailing 12-Month Free Cash Flow is £-4.3 Mil, and Market Cap is £766.2 Mil. Therefore, Oxford BioMedica's FCF Yield % for today is -0.56%.

The historical rank and industry rank for Oxford BioMedica's FCF Yield % or its related term are showing as below:

LSE:OXB' s FCF Yield % Range Over the Past 10 Years
Min: -36.85   Med: -3.91   Max: 6.32
Current: -0.56


During the past 13 years, the highest FCF Yield % of Oxford BioMedica was 6.32%. The lowest was -36.85%. And the median was -3.91%.

LSE:OXB's FCF Yield % is ranked better than
81.13% of 1415 companies
in the Biotechnology industry
Industry Median: -9.62 vs LSE:OXB: -0.56

Oxford BioMedica's FCF Margin % for the quarter that ended in Dec. 2025 was -6.67%.


Oxford BioMedica FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Oxford BioMedica FCF Yield % Related Terms


Oxford BioMedica FCF Yield % Historical Data

* Premium members only.

The historical data trend for Oxford BioMedica's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioMedica FCF Yield % Chart

Oxford BioMedica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 -6.79 -18.01 -13.07 -0.57

Oxford BioMedica Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.37 -28.19 -6.36 1.26 -1.71

LSE:OXB vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Oxford BioMedica's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioMedica FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's FCF Yield % falls into.


LSE:OXB
68GF Score
Oxford BioMedica PLC LSE:OXB
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxford BioMedica FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Oxford BioMedica's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.254 / 745.03984
=-0.57%

Oxford BioMedica's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.375 * 2 / 745.03984
=-1.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -0.56 mean?
Oxford BioMedica (LSE:OXB) has a FCF Yield % of -0.56 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Oxford BioMedica and its competitors. According to the industry distribution chart, Oxford BioMedica ranks #267 out of 1415 companies in the Biotechnology industry, placing it in the top 18.9%.
Is Oxford BioMedica's FCF Yield % too high?
Oxford BioMedica's current FCF Yield % is -0.56. Based on the distribution chart, Oxford BioMedica ranks #267 out of 1415 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Oxford BioMedica has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oxford BioMedica's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford BioMedica ranks #267 out of 1415 companies for FCF Yield %. This places Oxford BioMedica in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Oxford BioMedica and its competitors. Oxford BioMedica's current FCF Yield % is -0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioMedica stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioMedica (LSE:OXB) is currently considered Modestly Overvalued. The stock's GF Value™ is £5.36, compared to a current price of £6.33 — trading 18.1% above its estimated fair value. The current FCF Yield % is -0.56. Oxford BioMedica's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Oxford BioMedica (LSE:OXB), the current FCF Yield % is -0.56 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxford BioMedica (LSE:OXB) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford BioMedica stock appears to be overvalued. The current stock price of £6.33 is trading 18.1% above its estimated GF Value™ of £5.36. GuruFocus considers Oxford BioMedica to be Modestly Overvalued.

Key valuation signals for LSE:OXB:

  • FCF Yield %: -0.56
  • GF Value™: £5.36 vs. price of £6.33 (18.1% above fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the LSE:OXB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxford BioMedica Business Description

Other Exchanges OXBDF:USAOXBl:UKOXO:Germany
Address Transport Way, Windrush Court, Oxford, GBR, OX4 6LT
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. Geographically, it derives maximum revenue from the United States, and the rest from Europe, the UK, and the Rest of the world.
68GF Score

Get the complete analysis for LSE:OXB

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£6.33
Price
£5.36
GF Value